Dyslipidaemia Drug Market Forecasting a 3.5% CAGR Surge, Reaching...

added blog Business

2023-12-01 10:44:36 -

Dyslipidaemia Drug Market Forecasting a 3.5% CAGR Surge, Reaching 17.76 Billion USD by 2029

The industry for Dyslipidaemia Drug Market is expected to reach a significant value of USD 13.58 billion in 2022 and is expected to rise at a steady rate of 3.5% CAGR over the course of the forecast period. According to the crystal ball, revenue will rise sharply and reach about 17.76 billion USD by 2029. Vascular illnesses are significantly increased by dyslipidaemia, which...

0 Comments 0 Shares 0 Reviews